- Home
- MGY vs VKTX Comparison
MGY vs VKTX Comparison
Compare MGY & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGY | VKTX |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.0B |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MGY | VKTX |
|---|---|---|
| Price | $25.28 | $25.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 21 |
| Target Price | $32.88 | ★ $94.50 |
| AVG Volume (30 Days) | 3.5M | ★ 6.8M |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $1,311,845,000.00 | N/A |
| Revenue This Year | $53.53 | N/A |
| Revenue Next Year | $35.85 | N/A |
| P/E Ratio | $105.71 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $21.07 | $24.94 |
| 52 Week High | $32.76 | $43.15 |
Technical Indicators
Market Signals| Indicator | MGY | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.29 | 39.23 |
| Support Level | $25.24 | N/A |
| Resistance Level | $27.96 | $35.57 |
| Average True Range (ATR) | 0.65 | 1.40 |
| MACD | 0.21 | -0.16 |
| Stochastic Oscillator | 77.03 | 16.13 |
Price Performance
Historical ComparisonAbout MGY Magnolia Oil & Gas Corporation
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area of South Texas, where it targets the Eagle Ford Shale and Austin Chalk formations. It focuses on generating value for shareholders by delivering steady, moderate annual production growth resulting from its capital spending philosophy. The company operates in only one segment and derives the majority of its revenue from the sale of crude oil, natural gas, and natural gas liquids (NGLs).
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.